Pfizer Animal Health launches Fostera™ PCV
a new porcine circovirus vaccine
Kirkland, QC – Nearly every pig in Canada receives a vaccine for protection against porcine circovirus (PCV), and now swine producers have a new option for efficacious protection with the registration of Fostera PCV from Pfizer Animal Health.
Fostera PCV is labeled for use as an aid in preventing viremia and an aid in the control of PCV2 related lymphoid depletion for pigs three weeks of age and older. Fostera PCV provides four months of immunity against PCV in a single 2 mL dose.
“Fostera PCV offers Canadian swine veterinarians and producers a new choice for long-lasting, consistent protection against PCV,” says Walter Heuser, DVM, Swine Business Unit Director for Pfizer Animal Health. “Additionally, with our new one day of age claim for RespiSure-ONE®, we provide an innovative mycoplasma and circovirus vaccination program which gives veterinarians and their producers the flexibility to vaccinate for these key pathogens before disease challenge, giving the pigs the best coverage possible.”
Manufactured with the highest quality standards, Fostera PCV is backed by a sales and technical team dedicated to serving the Canadian swine industry, a unique producer loyalty program, and industry leading Pfizer training programs to improve on-farm productivity and herd health.
Fostera PCV is available exclusively through Canadian veterinarians.
Pfizer Animal Health Canada, headquartered in Kirkland, Quebec, is a subsidiary of Pfizer Inc., a research-based global health care company. Pfizer Animal Health Canada is committed to enhancing the health and wellness of animals and the productivity of livestock by delivering innovative quality products to the veterinary profession and to producers. The company’s products for livestock and companion animals include antibiotics, vaccines, feed supplements, and other veterinary items. www.PfizerAH.com